版本:
中国

BRIEF-Galena Biopharma presents positive interim safety data on NeuVax clinical trial

April 4 Galena Biopharma Inc

* Galena Biopharma presents positive interim safety data on the neuva (nelipepimut-s) clinical trial in combination with trastuzumab in high-risk HER2 3+ patients at the AACR annual meeting 2017

* Galena Biopharma Inc says in trial, there were no significant clinicopathologic differences between groups Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐